SCHEMBL1455296

SCHEMBL1455296

C[CH]CCC(C)Oc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
SLC6A4 P31645 1/20 0.39
LMNA P02545 1/20 0.37
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37
MAOA P21397 2/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
MAOB P27338 1/20 0.37
NISCH Q9Y2I1 1/20 0.37
LTA4H P09960 1/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.35
PTGS1 P23219 1/20 0.34
SIGMAR1 Q99720 2/20 0.34
GPR88 Q9GZN0 1/20 0.34
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1454212 0.89 MTNR1A (0.42) MTNR1AMTNR1BSLC6A4LMNACHRNB4
SCHEMBL1454910 0.83 SIGMAR1 (0.36) MTNR1AMTNR1BSIGMAR1
SCHEMBL1454571 0.80 MTNR1A (0.47) MTNR1AMTNR1BSLC6A4LMNACHRNB4
SCHEMBL1455125 0.78 SLC6A4 (0.37) MTNR1AMTNR1BSLC6A4MAOAADRA2A
SCHEMBL1454240 0.78 MTNR1A (0.49) MTNR1AMTNR1BSLC6A4LMNALTA4H
SCHEMBL1454315 0.77 SLC6A4 (0.36) MTNR1AMTNR1BSLC6A4LMNAMAOA
SCHEMBL7951815 0.76 MAOA (0.38) MTNR1AMTNR1BSLC6A4LMNACHRNB4
SCHEMBL7582723 0.76 MTNR1A (0.47) MTNR1AMTNR1BSLC6A4LMNAMAOA
SCHEMBL218384 0.76 MTNR1A (0.47) MTNR1AMTNR1BSLC6A4LMNACHRNB4
SCHEMBL331604 0.76 MTNR1A (0.47) MTNR1AMTNR1BSLC6A4LMNACHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910617-B2 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound SANKYO COMPANY, LIMITED (JP) 2011-03-22 US disclosed
US-20070191468-A1 Amino alcohol compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2007-08-16 US disclosed
EP-1733724-A1 AMINO ALCOHOL COMPOUND Sankyo Company, Limited (JP) 2006-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191468-A1 Amino alcohol compound ADH1A, ADH1C, BCAT1 MTNR1A 3312/4885MTNR1B 2386/4885SLC6A4 1912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.